MARKET

TCMD

TCMD

Tactile Systems
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.87
-0.63
-6.63%
Opening 11:22 05/24 EDT
OPEN
9.24
PREV CLOSE
9.50
HIGH
9.58
LOW
8.87
VOLUME
91.11K
TURNOVER
583.87K
52 WEEK HIGH
57.64
52 WEEK LOW
8.87
MARKET CAP
176.86M
P/E (TTM)
-7.0152
1D
5D
1M
3M
1Y
5Y
Tactile Systems Tech Earnings Perspective: Return On Capital Employed
Tactile Systems Tech (NASDAQ:TCMD) brought in sales totaling $47.98 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 107.71%, resulting in a loss of $15.57 million.
Benzinga · 05/10 14:13
Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of -35.48% and 6.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/02 21:45
Tactile Systems Tech: Q1 Earnings Insights
Tactile Systems Tech (NASDAQ:TCMD) reported its Q1 earnings results on Monday, May 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Benzinga · 05/02 21:29
BRIEF-Tactile Systems Technology Reports Q1 Loss Per Share $0.78
reuters.com · 05/02 21:00
Tactile Systems Tech Q1 EPS $(0.78) Misses $(0.28) Estimate, Sales $47.98M Beat $44.94M Estimate; Reaffirms Guidance
Tactile Systems Tech (NASDAQ:TCMD) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.28) by 178.57 percent. This is a 550 percent decrease over losses of $(0.12) per share
Benzinga · 05/02 20:40
Tactile Systems Technology GAAP EPS of -$0.78 misses by $0.50, revenue of $48M beats by $3.06M
Tactile Systems Technology press release (NASDAQ:TCMD): Q1 Non-GAAP net loss of $8.4M. Revenue of $48M (+12.2% Y/Y) beats by $3.06M.
Seekingalpha · 05/02 20:22
-- Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Posts Q1 Loss $-0.78, vs. Street Est of $-0.21
MT Newswires · 05/02 16:17
Earnings Outlook For Tactile Systems Tech
Tactile Systems Tech (NASDAQ:TCMD) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Tactile Systems Tech will report an earnings per share (EPS) of...
Benzinga · 04/29 20:25
More
No Data
Learn about the latest financial forecast of TCMD. Analyze the recent business situations of Tactile Systems through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

75.00%Strong Buy
25.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average TCMD stock price target is 30.67 with a high estimate of 35.00 and a low estimate of 28.00.
High35.00
Average30.67
Low28.00
Current 8.87
EPS
Actual
Estimate
-0.59-0.41-0.22-0.04
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 218
Institutional Holdings: 22.27M
% Owned: 111.68%
Shares Outstanding: 19.94M
TypeInstitutionsShares
Increased
45
918.78K
New
20
1.43M
Decreased
43
1.46M
Sold Out
24
1.19M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.74%
Healthcare Equipment & Supplies
-1.53%
Key Executives
Non-Executive Chairman/Independent Director
William Burke
President/Chief Executive Officer/Director
Daniel Reuvers
Chief Financial Officer
Brent Moen
Senior Vice President/Director of Sales
Eric Pauls
Senior Vice President/Director of Marketing
Kristie Burns
Independent Director
Valerie Asbury
Independent Director
Sheri Dodd
Independent Director
Raymond Huggenberger
Independent Director
Deepti Jain
Independent Director
D. Brent Shafer
Independent Director
Peter Soderberg
No Data
No Data
About TCMD
Tactile Systems Technology, Inc. is a medical technology company focused on developing medical devices for the treatment of chronic diseases. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. It is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. It possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

Webull offers kinds of Tactile Systems Technology Inc stock information, including NASDAQ:TCMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TCMD stock methods without spending real money on the virtual paper trading platform.